Skip to main content

Table 2 NLR among several clinicopathological variables

From: Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients

Parameter

NLR (Median + IR)

p value

Gender

 Male

2.59 (2.05–3.32)

NS

 Female

2.51 (1.87–3.69)

Age

  ≥ 72 years

2.72 (2.14–3.76)

0.016

  < 72 years

2.41 (1.82–3.16)

Primary tumor

 Right colon

2.67 (2.13–3.76)

 

 Left colon

2.65 (1.89–3.42)

 Rectum

2.48 (1.81–3.08)

 Right VS Left colon

2.67 (2.13–3.76) VS 2.49 (1.85–3.24)

NS

 Colon VS Rectum

2.67 (2.10–3.68) VS 2.48 (1.81–3.08)

NS

Differentiation

 Low

2.7 (2.2–3.44)

NS

 Medium + High

2.51 (1.88–3.4)

T

 T1

1.88 (1.53–2.98)

NS

 T2

2.49 (1.85–3.14)

 T3

2.6 (2.0–3.43)

 T4

2.76 (2.27–5.22)

N

 N0

2.58 (1.92–3.37)

NS

 N1

2.34 (1.85–3.45)

 N2

2.78 (2.29–3.95)

No of lymph node harvested

  < 12

2.37 (2.09–3.28)

NS

  ≥ 12

2.58 (1.92–3.43)

No of infiltrated lymph nodes

 0 (n = 198)

2.58 (1.96–3.43)

NS

 1 (n = 21)

2.22 (1.73–3.82)

  ≥ 2 (n = 77)

2.55 (1.91–3.33)

Stage

 Stage I

2.26 (1.74–2.87)

0.049

 Stage II

2.67 (2.16–3.45)

 Stage III

2.55 (1.96–3.60)

 Stage I VS Stage II + III

2.26 (1.74–2.87) VS 2.62 (2.07–3.48)

Perineural invasion

 No

2.53 (1.91–3.30)

< 0.001

 Yes

3.45 (2.24–6.00)

Vascular invasion

 No

2.54 (1.91–3.36)

0.034

 Yes

2.68 (2.17–4.18)

Lymphatic invasion

 No

2.53 (1.91–3.40)

NS

 Yes

2.63 (2.12–3.69)

Recurrence

 No

2.54 (1.96–3.37)

NS

 Yes

2.79 (1.83–4.03)

Site of recurrence

 Local (n = 15)

2.11 (1.56–4.03)

NS

 Distant (n = 16)

3.05 (2.07–3.89)